Full Text View
Tabular View
No Study Results Posted
Related Studies
KUL0401: An Open-Label Pilot Study of Oxatomide in Steroid-Naive Duchenne Muscular Dystrophy
This study has been completed.
Study NCT00033813   Information provided by Cooperative International Neuromuscular Research Group
First Received: April 10, 2002   Last Updated: April 4, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Muscular Dystrophy, Duchenne
Additional conditions recognized in this trial
Muscular Dystrophies
More general conditions related to this trial
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Muscular Diseases
Muscular Disorders, Atrophic
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Interventions listed in this trial
Oxatomide (tinset)
Additional drug interventions recognized in this trial
Oxatomide
More general drug interventions related to this trial
Anti-Allergic Agents
Anti-Asthmatic Agents
Histamine Agents
Histamine Antagonists
Histamine H1 Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Cooperative International Neuromuscular Research Group


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services